A, K., I, M., A, R., MS, U., R, L., FD, A., . . . MB, F. (2025). Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177Lu-based Radioimmunotherapy of Lung Cancer. Nanotheranostics, 9(1), 82. https://doi.org/10.7150/ntno.101699
Chicago Style (17th ed.) CitationA, Kurniawan, Mahendra I, Rizaludin A, Utama MS, Lesmana R, Ayuningtyas FD, Dewanti MR, Syarif DG, and Febrian MB. "Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177Lu-based Radioimmunotherapy of Lung Cancer." Nanotheranostics 9, no. 1 (2025): 82. https://doi.org/10.7150/ntno.101699.
MLA (9th ed.) CitationA, Kurniawan, et al. "Dual Potential of Cetuximab Conjugated Hydroxyapatite Zirconium Nanoparticle as Nanocarrier for Radioenhancer in X-Ray Dynamic Therapy and 177Lu-based Radioimmunotherapy of Lung Cancer." Nanotheranostics, vol. 9, no. 1, 2025, p. 82, https://doi.org/10.7150/ntno.101699.
